VKTX

Viking Therapeutics (VKTX)

About Viking Therapeutics (VKTX)

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Details

Daily high

$30.75

Daily low

$29.04

Price at open

$29.84

52 Week High

$89.10

52 Week Low

$24.41

Market cap

3.4B

Dividend yield

0.00%

Volume

1.3M

Avg. volume

5.3M

P/E ratio

-29.80

Viking Therapeutics News